Using the established ANCA scoring systems, MPO-ANCA GN was classified more frequently as ARRS high risk including loss of eGFR (Figure 3A), consistent with our aforementioned findings, i.e., that MPO-ANCA GN showed more severe deterioration of kidney function. Here, MPO is linked to ganglioneuroma.